Cusabio Polyclonal Antibodies
Phospho-EZR (Thr567) Antibody | CSB-PA988068
- SKU:
- CSB-PA988068
- Availability:
- 3 to 7 Working Days
- Size:
- 100ul
Description
Phospho-EZR (Thr567) Antibody | CSB-PA988068 | Cusabio
Phospho-EZR (Thr567) Antibody is Available at Gentaur Genprice with the fastest delivery.
Online Order Payment is possible or send quotation to info@gentaur.com.
Product Type: Polyclonal Antibody
Target Names: EZR
Aliases: Cytovillin; EZRI; VIL2; Villin 2; p81
Background: Probably involved in connections of major cytoskeletal structures to the plasma membrane. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with PLEKHG6, required for normal macropinocytosis.
Zhou R, et al. (2005) J Cell Sci: 118 (Pt 19) : 4381-91
Shiue H, et al. (2005) J Biol Chem: 280 (2) : 1688-95
Zhao H, et al. (2004) Proc Natl Acad Sci U S A: 101 (25) : 9485-90
Fievet BT, et al. (2004) J Cell Biol: 164 (5) : 653-9
Isotype: IgG
Conjugate: Non-conjugated
Clonality: Polyclonal
Uniport ID: P15311
Host Species: Rabbit
Species Reactivity: Human, Mouse, Rat
Immunogen: Peptide sequence around phosphorylation site of threonine 567 (Y-K-T (p) -L-R) derived from Human Ezrin.
Immunogen Species: Human
Applications: ELISA, WB
Tested Applications: ELISA, WB;WB:1:500-1:1000
Purification Method: Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
Dilution Ratio1: ELISA:1:2000-1:10000
Dilution Ratio2: WB:1:500-1:1000
Dilution Ratio3:
Dilution Ratio4:
Dilution Ratio5:
Dilution Ratio6:
Buffer: Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form: liquid
Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Initial Research Areas: Signal Transduction
Research Areas: Cancer;Signal transduction